drugset
drugset / Trial / NCT03967548

The Germinal Peptide Eye Drops in Healthy Volunteers in a Clinical Study

NCT03967548 ↗

Phase 1 Completed 106 enrolled Zhaoke (Guangzhou) Ophthalmology Pharmaceutical Ltd.
NaSingle-groupOpen-labelTreatment

Summary

The subjects of this study were healthy subjects, who were given medicine in a single dose group: 0.004%.

Timeline

Start
2021-04-09
Primary completion
2021-05-16
Completion
2021-06-15

Drugs

EvaluationDrugModalityDoseRoute
Subject Germinal peptide Peptide 0.004 % Topical

Indications

corneal disorder